25 participants
Thalidomide Anti-Angiogenesis Therapy of Relapsed or Refractory Leukemia
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2010-07-02
- Start Date:
- 1998-08-31
Conditions
- Leukemia
Interventions
- DRUG
No Results Yet